FDG uptake in primary squamous cell carcinoma of the head and neck: The relationship between overexpression of glucose transporters and hexokinases, tumour proliferation and apoptosis

NuklearMedizin

Volumn 50, Issue 1, 2011, Pages 15-21

  Deron, Philippe ^a   Vangestel, C ^a   Goethals, I ^a   De Potter, A ^a   Peeters, M ^b   Vermeersch, H ^a   Van De Wiele, C ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Apoptosis; FDG PET CT; GLUT 1; Head and neck; Squamous cell carcinoma

Indexed keywords

CASPASE 3; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; HEXOKINASE; HEXOKINASE 1; HEXOKINASE 3; IOHEXOL; IOMEPROL; KI 67 ANTIGEN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CELL PROLIFERATION; CLINICAL ARTICLE; DRUG UPTAKE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MALE; SQUAMOUS CELL CARCINOMA;

ADOLESCENT; ADULT; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HEAD AND NECK NEOPLASMS; HEXOKINASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; UP-REGULATION; YOUNG ADULT;

EID: 79952097013     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0324-10-06     Document Type: Article

References (27)

1. Chin D, Boyle GM, Porceddu S et al. Head and neck cancer: past, present and future. Expert Rev Anticancer Ther 2006; 6: 1111-1118. (Pubitemid 44203388)
2. De Witte O, Hildebrand J, Luxen A, Goldman S. Acute effect of carmustine on glucose metabolism in brain and glioblastoma. Cancer 1994; 74: 2836-2842. (Pubitemid 24340552)
3. Duijsings D, Houweling M, Vaandrager AB et al. Hexadecyl-phosphocholine causes rapid cell death in canine mammary tumour cells. Eur J Pharmacol 2004; 502: 185-193. (Pubitemid 39336484)
4. Fujibayashi Y, Waki A, Sakahara H et al. Transient increase in glycolytic metabolism in cultured tumor cells immediately after exposure to ionizing radiation : from gene expression to deoxyglucose uptake. Radiat Res 1997; 147: 729-734. (Pubitemid 27247187)
5. Furuta M, Hasegawa M, Hayakawa K et al. Rapid rise in FDG uptake in an irradiated human tumor xenograft. Eur J Nucl Med 1997; 24: 435-438. (Pubitemid 27183049)
6. Haberkorn U, Reinhardt M, Strauss LG et al. Metabolic design of combination therapy: use of enhanced fluorodeoxyglucose uptake caused by chemotherapy. J Nucl Med 1992; 33: 1981-1987.
7. Jacob R, Welkoborsky HJ, Mann WJ et al. [Fluorine-18]fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck. ORL J Otorhinolaryngol Relat Spec 2001; 63: 307-313. (Pubitemid 32786188)
8. Joost HG, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members. Mol Membr Biol 2001; 18: 247-256. (Pubitemid 34052684)
9. Kunkel M, Reichert TE, Benz P et al. Over-expression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 2003; 97: 1015-1024. (Pubitemid 36173153)
10. Li SJ, Guo W, Ren GX et al. Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F] fluoro-2-deoxy-D-glucose accumulation in positron emission tomography. Br J Oral Maxillofacial Surg 2008; 46: 180-186. (Pubitemid 351337627)
11. 18F-FDG in primary head and neck cancer correlates with survival. Nuklearmedizin 2008; 47: 80-85.
12. Macheda ML, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 2005; 202: 654-662. (Pubitemid 40175840)
13. Machtay M, Natwa M, Andrel J et al. Pretreatment FDG-PET standardized uptake values as a prognostic factor for outcome in head and neck cancer. Head Neck 2009; 31: 195-201.
14. Maruyama I, Sadato N, Waki A et al. Hyperacute changes in glucose metabolism of brain tumors after stereotactic radiosurgery: a PET study. J Nucl Med 1999; 40: 1085-1090. (Pubitemid 29315495)
15. Minn H, Lapela M, Klemi PJ et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 1997; 38: 1907-1911. (Pubitemid 28030920)
16. Parkin DM, Läärä E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988; 41: 184-197.
17. Rota Kops E, Krause BJ. The influence of filtered-back projection and iterative reconstruction on partial volume correction in PET. Nuklearmedizin 2005; 44: 99-106. (Pubitemid 40827224)
18. 18F-FDG PET for detecting recurrent head and neck cancer, local lymph node involvement and distant metastases. Comparison of qualitative visual and semiquantitative analysis. Nuklearmedizin 2004; 43: 91-101.
19. Smith TA, Blaylock MG. Treatment of breast tumor cells in vitro with the mitochondrial membrane potential dissipater valinomycin increases 18F-FDG incorporation. J Nucl Med 2007; 48: 1308-1312. (Pubitemid 47242796)
20. Srinivas SM, Dhurairaj T, Basu S et al. A recovery coefficient method for partial volume correction of PET images. Ann Nucl Med 2009; 23: 341-348.
21. Tian M, Zhang H, Nakasone Y et al. Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study. Eur J Nucl Med Mol Imaging 2004; 31: 5-12. (Pubitemid 38133535)
22. 18F-FDG PET. J Nucl Med 2010; 51: 268-276.
23. Van Waarde A, Been LB, Ishiwata K et al. Early response of sigma-receptor ligands and metabolic PET tracers to 3 forms of chemotherapy: an in vitro study in glioma cells. J Nucl Med 2006; 47: 1538-1545. (Pubitemid 47544943)
24. Vermeersch H, Loose D, Ham H et al. Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers. Eur J Nucl Med 2003; 30: 1689-1700. (Pubitemid 38017438)
25. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-314.
26. Wood IS, Trayhurn P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr 2003; 89: 3-9. (Pubitemid 36187532)
27. 18F]fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 1999; 35: 1773-1782.